Gilead coronavirus treatment trial shows rapid recovery: Report
Gilead Sciences’ potential coronavirus treatment is reportedly showing signs of optimism in trial. FOX Business’ Jackie DeAngelis with more.
A coronavirus test by biopharmaceutical company Gilead failed a clinical trial in China, the Financial Times reported.
Continue Reading Below
|GILD||GILEAD SCIENCES INC.||76.57||-4.74||-5.83%|
The antiviral drug remdesivir did not help speed the recovery of COVID-19 patients, according to FT and Stat News, which both cite a summary of the report that was initially shared by the World Health Organization before it was taken down.